In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d Journal Articles

abstract

• WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, et al. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA. 2021;326:499-518. 34228774.

authors

• Lo, Carson KL
• Chagla, Zain

status

• published 

publication date

• November 2021

has subject area

• 1103 Clinical Sciences (FoR)
• 1117 Public Health and Health Services (FoR)
• Antibodies, Monoclonal, Humanized (MeSH)
• COVID-19 Drug Treatment (MeSH)
• Humans (MeSH)
• SARS-CoV-2 (MeSH)

published in

• ACP journal club  Journal

keywords

• Antibodies, Monoclonal, Humanized
• COVID-19 Drug Treatment
• Humans
• SARS-CoV-2

Digital Object Identifier (DOI)

• 10.7326/acpj202111160-125

PubMed ID

• 34724398

start page

• JC125

end page

• JC125

volume

• 174

issue

• 11